Cart
sales@molnova.com
Losartan Carboxaldehyde
CAS No. 114798-36-6
Losartan Carboxaldehyde( —— )
Catalog No. M21093 CAS No. 114798-36-6
Losartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | Get Quote |
|
| 10MG | 177 | Get Quote |
|
| 25MG | 385 | Get Quote |
|
| 50MG | 575 | Get Quote |
|
| 100MG | 801 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLosartan Carboxaldehyde
-
NoteResearch use only, not for human use.
-
Brief DescriptionLosartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
-
DescriptionLosartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114798-36-6
-
Formula Weight420.8
-
Molecular FormulaC22H21ClN6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (296.99 mM)
-
SMILESCCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kramer C. Angiotensin II Receptor-Independent Antiinflammatory and Antiaggregatory Properties of Losartan: Role of the Active Metabolite EXP3179[J]. Circulation Research 2002 90(7):770-776.
molnova catalog
related products
-
Chemocoxib A
Chemocoxib A is a highly potent, selective, cytotoxic COX-2 inhibitor with IC50 of 290 nM and 90 nM for wt mCOX-2 and R120Q COX-2 mutant respectively.
-
Phenylbutazone
Phenylbutazone(Butazolidin, Butatron) is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis.
-
Sifalimumab
Sifalimumab (MEDI-545) is a monoclonal antibody that targets IFNα and suppresses abnormal immune activity by binding to interferon-alpha.Sifalimumab is used for the treatment of moderate to severe SLE.
